NEWS: Bournemouth, UK – 7th April 2015: Solentim Limited has announced relocation to a new global headquarters. The new facility is located in Wimborne, UK.
The move provides the space for a significant increase in production and assembly to meet the sales demand for their Cell Metric™ product line. Additional people have been hired in production, assembly, software development and logistics. In line with Solentim’s commitment to the local region, many of these new team members have been recruited from within the county of Dorset.
The new offices also provide a training facility for the company’s international distributors and provide capacity for new products under development.
Aaron Figg, Director at Solentim, commented “the new facility provides us with an approximate four-fold increase in space which primarily allows us to increase our manufacturing output and efficiency, in line with our recent ISO 9001 certification.” Mr Figg continued, “Following the strong sales performance of Cell Metric™ systems throughout 2014 – notably in the US market – the first quarter of 2015 has been our best quarter in the company’s history, and reflects increasing demand for our products across all regions including an expanding international distributor network”.
Solentim had also recently announced their expansion within the US with set up of an office near Philadelphia.
Contact details for the new Solentim global headquarters are:-
6 Aerial Park
Dorset, BH21 7NL
Tel: +44 (0)1202 798510
------- ENDS -------
Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedicated to the development of innovative tools to shorten steps in the upstream cell line development workflow. The Cell Metric™ product range consists of bio-analytical imaging stations for rapid clone screening and documented proof of monoclonality for the FDA and other regulatory bodies. To find more information visit www.solentim.com
Dr Ian Taylor
E: [email protected]